Mark Lappe - Sep 12, 2024 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Role: Chief Executive Officer, Director
Signature: /s/ Kelly D. Deck, as attorney-in-fact for Mark P. Lappe
Stock symbol: INBX
Transactions as of: Sep 12, 2024
Transactions value $: $629,117
Form type: 4
Date filed: 9/16/2024, 05:12 PM
Previous filing: Sep 10, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INBX	Common Stock	Purchase	$406K	+27K	+4.05%	$15.05	693K	Sep 12, 2024	By the Lappe Family Trust	F1, F2
transaction	INBX	Common Stock	Purchase	$223K	+13K	+1.88%	$17.13	706K	Sep 16, 2024	By the Lappe Family Trust	F2, F3
holding	INBX	Common Stock						165K	Sep 12, 2024	By Lappe Descendants' Trust	F4
holding	INBX	Common Stock						54.9K	Sep 12, 2024	The Mark Paul Lappe Roth IRA

Showing 1 to 4 of 4 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were purchased in multiple transactions at prices ranging from $15.00 to $15.10, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2	These securities are directly owned by the Lappe Family Trust. Mark P. Lappe is a trustee of the Lappe Family Trust and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Lappe Family Trust.
F3	The shares were purchased in multiple transactions at prices ranging from $16.70 to $17.695, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F4	These securities are directly owned by a trust, for the benefit of the reporting person's immediate family. Mark P. Lappe, as an immediate family member of the beneficiaries of the trust, may be deemed to indirectly beneficially own the securities owned by the trust.